GOSS · Serenity viewpoints

Serenity @aleabitoreddit

448.0K

Focused on AI photonics and semiconductor supply chains — sourcing asymmetric setups from bottoms-up value-chain research. Tracks CPO & optical modules closely, with ongoing deep-dives on SIVE, AAOI, LITE, POET.

Quick verdict

GOSS is neutral (0 bull · 0 bear)

Named by Anthropic's Fable 5.1 Max for potential returns related to seralutinib.

Last spoke: 09/06/2026, 14:23 · no conviction

8-10 confidence views use larger markers▲ Bull▼ Bear● Mention

View History (1, newest first)

09/06/2026, 14:23UTCMentionView on X →
I asked OpenAI Astra Ultra + Anthropic Fable 5.1 Max to make me a 5x-10x return type portfolio in 1 year. Burnt a lot of credits, and the results are in: OpenAI: - $KYTX (autoimmune CAR-T results) - $PRQR (human RNA-editing datasets) - $VSTM (KRAS cancer-drug) - $CNTB (asthma and COPD) - $RANI (oral biologics) - $IVA (MASH) - $SILC (networking + inference hardware) - $AMPX (batteries) - $EOSE (batteries) - $ZVRA (rare-disease drug growth) Anthropic: - $INO (respiratory papillomatosis) - $CAPR (PDUFA for deramiocel) - $GOSS (seralutinib) - $SLS (Phase 3 binary) - $IREN (familiar face) - $WULF (familiar face) - $OKLO (nuclear) - $SMR (nuclear) - $RGTI (quantum) - $QBTS (quantum) *Disclosure don't own any of these aside from 1 share in IREN, not a recommendation, just TLDR of LLM output for educational purposes. So very interesting results: Our beloved AGI Astra prefers really obscure biotech I've never heard about. And a few familiar names like $EOSE and $AMPX. And Fable... yeah idk, feels like it learned a little too much from /r/wallstreetbets and X but maybe it's right, who knows. Anyway no judgement, I'll save this and revisit it in a few months. If one of them actually delivers... I'll be impressed.

Ongoing takes on other optical names too

Beyond GOSS, his viewpoint library also covers:

$SIVE · 269 takes $NVDA · 170 takes $AAOI · 159 takes

All tracked tickers →Institutional, insider & congressional activity →

View History (1, newest first)

09/06/2026, 14:23UTCMentionView on X →

I asked OpenAI Astra Ultra + Anthropic Fable 5.1 Max to make me a 5x-10x return type portfolio in 1 year. Burnt a lot of credits, and the results are in: OpenAI: - $KYTX (autoimmune CAR-T results) - $PRQR (human RNA-editing datasets) - $VSTM (KRAS cancer-drug) - $CNTB (asthma and COPD) - $RANI (oral biologics) - $IVA (MASH) - $SILC (networking + inference hardware) - $AMPX (batteries) - $EOSE (batteries) - $ZVRA (rare-disease drug growth) Anthropic: - $INO (respiratory papillomatosis) - $CAPR (PDUFA for deramiocel) - $GOSS (seralutinib) - $SLS (Phase 3 binary) - $IREN (familiar face) - $WULF (familiar face) - $OKLO (nuclear) - $SMR (nuclear) - $RGTI (quantum) - $QBTS (quantum) *Disclosure don't own any of these aside from 1 share in IREN, not a recommendation, just TLDR of LLM output for educational purposes. So very interesting results: Our beloved AGI Astra prefers really obscure biotech I've never heard about. And a few familiar names like $EOSE and $AMPX. And Fable... yeah idk, feels like it learned a little too much from /r/wallstreetbets and X but maybe it's right, who knows. Anyway no judgement, I'll save this and revisit it in a few months. If one of them actually delivers... I'll be impressed.